Form 4 for BHC Bausch Health Companies Inc.
Accepted 2022-01-20 00:00:00 ET · period of report 2022-01-18 · accession 0000950103-22-000900 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-20 | 2022-01-18 | BHC | Spurr Robert | U.S. Pres-Pharma Business | S - Sale | $26.63 | -3,251 | 63.5K | -5% | -$86.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2022-01-18 | S | D | 3,251 | $26.63 | 63,550 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021. |